DOMAJOR, NCT03912389 / 2018-004791-36: Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC |
|
|
| Recruiting | 3 | 292 | Europe, RoW | BCD-100, Pemetrexed, Cisplatin (or carboplatin), Placebo | Biocad | Non-Squamous Non-Small Cell Neoplasm of Lung | 12/23 | 12/23 | | |